Human substance P receptor binding mode of the antagonist drug aprepitant by NMR and crystallography
The FDA approved drug aprepitant is an antagonist of the Neurokinin 1 receptor (NK1R). Here the authors present aprepitant bound NK1R crystal structures and use NMR spectroscopy to gain further insights into the dynamics of aprepitant binding, which is of interest for further drug development.
Guardado en:
Autores principales: | Shuanghong Chen, Mengjie Lu, Dongsheng Liu, Lingyun Yang, Cuiying Yi, Limin Ma, Hui Zhang, Qing Liu, Thomas M. Frimurer, Ming-Wei Wang, Thue W. Schwartz, Raymond C. Stevens, Beili Wu, Kurt Wüthrich, Qiang Zhao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1fea1939297743138267a644666827c0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Insights into the mechanism of ligand binding to octopine dehydrogenase from Pecten maximus by NMR and crystallography.
por: Sander H J Smits, et al.
Publicado: (2010) -
Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy.
por: Sonja Ständer, et al.
Publicado: (2010) -
Crystallography reports
Publicado: (1993) -
Crystallography reviews
Publicado: (1987) -
Journal of chemical crystallography
Publicado: (1994)